参考文献/References:
[1]Nkomo VT,Gardin JM,Skelton TN,et al.Burden of valvular heart diseases: a population-based study [J].Lancet,2006,368(9540):1005-1011.[2]Hayek E,Gring CN,Griffin BP,et al.Mitral valve prolapse[J].Lancet,2005,365(9458):507-518.[3]Verma S,Latter DA,Bonow RO.Failed mitral TEER:are there lessons for decision making?[J]Am Coll Cardiol,2021,78(1):10-13.[4]潘文志,周达新,葛均波.中国二尖瓣反流患者人群数量的估测[J].中国胸心血管外科临床杂志,2021,28(5):495-498.[5]Gammie JS,Wilson P,Bartus K,et al.Transapical Beating-Heart Mitral Valve Repair With an Expanded Polytetrafluoroethylene Cordal Implantation Device : Initial Clinical Experience[J].Circulation,2016,134:189-197.[6]Gammie JS,Bartus K,Gackowski A,et al.Beating-heart mitral valve repair using a novel ePTFE cordal implantation device:a prospective trial[J].Journal of the American College of Cardiology,2018,71(1):25-36.[7]Seeburger J,Borger MA,Tschernich H,et al.Transapical beating heart mitral valve repair repair[J].Circ Cardiovasc Interv,2010,3:611-612.[8]Colli A,Manzan Z,Zucchetta F,et al.Transapical off-pump mitral valve repair with Neochord. implantation:Early clinical results[J].International Journal of Cardiology,2016,204:23-28.[9]顾捷,蒲朝霞,刘宪宝,等.经食管超声心动图引导NeoChord 人工腱索治疗二尖瓣后叶脱垂合并重度反流的初步研究[J].中华超声影像学杂志,2020,29(5):389-393.[10]Bajona P,Katz WE,Daly RC,et al.Beating-heart, off-pump mitral valve repair by implantation of artificial chordae tendineae: an acute in vivo animal study[J].Thorac Cardiovasc Surg,2009,137:188-193.[11]Nielsen SL,Hansen SB,Nielsen KO,et al.Imbalanced chordal force distribution causes acute ischemic mitral regurgitation: mechanistic insights from chordae tendineae force measurements in pigs[J].Thorac Cardiovasc Surg,2005,129:525-531.[12]Wang S,Meng X,Luo Z,et al.Transapical beating-heart mitral valve repair using an novel neochord implantation system [J].Ann Thorac Surg,2018,165(5):265-267.[13]Sidhu RS,Tyrrell BD,Welsh RC,et al.Transcatheter mitral valve intervention for chronic mitral regurgitation:a plethora of different technologies[J].Can J Cardiol,2018,34(9):1200-1209.[14]De Bonis.Mitral valve repair for functional mitral regurgitation in end-stage dilated cardiomyopathy: role of the “edge-to-edge” technique[J].Circulation,2005,112(9):402-408.[15]Feldman T,Kar S,Elmariah S,et al.Randomized comparison of percutaneous repair and surgery or mitral regurgitation 5-year resultsof EVERESTⅡ[J].Journal of the American College of Cardiology,2015,66(25):2844-2854.[16]Mack MJ,Lindenfeld J,Abraham WT,et al.3-year outcomes of transcatheter mitral valve repair in patients with heart failure [J].J Am Coll Cardiol,2021,77(8):1029-1040.[17]Lim DS,Smith RL,Zahr F,et al.Early outcomes from the CLASP IID trial roll-in cohort forprohibitive risk patients with degenerative mitral regurgitation[J].Catheter Cardiovasc Interv,2021,98(4):637-646.[18]潘文志,金沁纯,周达新.房性功能性二尖瓣反流的定义及经导管 缘对缘修复术对其治疗的可行性[J].华西医学,2021,36(9):248-251.[19]朱达,潘家华,骆志玲,等.新一代国产自锁式经导管二尖瓣缘对缘修复系统KokaclipTM首例置入[J].中国介入心脏学杂志,2022,30(1):75-77.[20]王斌,陈翔,苏茂龙,等.新一代国产经股静脉入径经导管二尖瓣缘对缘修复系统治疗高风险功能性二尖瓣反流首例报道[J].中国介入心脏学杂志,2021,29(7):416-418.[21]朱达,潘家华,骆志玲,等.新一代国产经导管二尖瓣缘对缘修复系统治疗重度二尖瓣反流两例[J].中国胸心血管外科临床杂志,2022,29(7):1083-1086.[22]Siminiak T,Wu JC,Haude M,et al.Treatment of functional mitral regurgitation by percutaneous annuloplasty:results of the TITAN trial[J].European Joernal of Heart Failure,2012,14(8):931-938.[23]Rogers JH,Thomas M,Morice MC,et al.Treatment of heart failure with associated functional mitral regurgitation using the ARTO system[J].JACC Cardiovasc Interv,2015,8(8):1095-1104.[24]Orban M,Braun D.Established interventions for mitral valve regurgitation:current evidence[J].Herz,2016,41(1):19-25.[25]Rogers JH,Boyd WD,Smith TW,et al.Early experience with Millipede IRIS transcatheter mitral annuloplasty[J].Ann Cardiothorac Surg,2018,7(6):780-786.[26]Braunwald NS,Cooper T,Morrow AG.Complete replacement of thr mitral valve:sucessful clinical application of a flexible polyurethance prosthesis[J].Thorac Cardiovasc Surg,1960,40:1-11.[27]Yoon SH,Bleiziffer S,Latib A,et al.Predictors of Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Replacement[J].JACC Cardiovasc Interv,2019,12(2):182-193.[28]Muller DWM,Sorajja P,Duncan A,et al.2-Year Outcomes of Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation[J].J Am Coll Cardiol,2021,78(19):1847-1859.[29]Zahr F,Song HK,Chadderdon SM,et al.30-Day Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: Intrepid TMVR Early Feasibility Study Results[J].JACC Cardiovasc Interv,2022,15(1):80-89.[30]Goel SS,Zuck V,Christy J,et al.Transcatheter Mitral Valve Therapy With Novel Supra-Annular AltaValve: First Experience in the United States[J].JACC Case Rep,2019,1(5):761-764.